Dolmar Land has been building communities for over 50 years. With more than 7,000 homes delivered to Filipinos, the company ...
For many Filipinos, owning a home feels increasingly out of reach. On one end, property prices continue to rise ...
MANILA, Philippines — Dolmar Land bags another major recognition at the recently concluded Dot Property Philippines Awards, as one of its flagship developments, Legacia, was awarded Best Investment ...
Buses use the route of a former railway line to avoid the congested A32 Bus drivers have been left "scared" to use a £20m expressway following anti-social behaviour and objects being thrown at ...
Buy a business, order stock and get money every irl hour! You can have employees, which get a cut from the income based on a formula that can be edited in the config. They can also buy stock for you ...
We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Tim Heffernan Tim Heffernan ...
Grilling season is here and Walmart’s exclusive Weber 22″ Star Spangled Charcoal Kettle is the perfect outdoor cooking accessory for Memorial Day weekend. While not on sale, the Walmart-exclusive ...
Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to turn its focus toward autoimmune diseases. The move isn’t shocking, as it ...
SBG Systems has released the New Ellipse, a firmware upgrade for the Ellipse product line. The system can now be used as an attitude and heading reference system or inertial navigation system. Powered ...
The two souls of Ljubljana merge in a new residential building In the two elevations of the Elipse building – an exact curve and a tormented series of wave-like terraces – the Austro-Hungarian rigor ...
This study is comparing 2 different types of routine surgery for prostate cancer that has a high risk of coming back.
EX103: A newly designed CD20×CD3 molecule in heavily pre-treated patients with B-cell non-Hodgkin lymphoma from a phase I/II trial. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results